The combination of medical expertise and technology, OncoStats aims to understand the problem it is solving and deliver instant feedback about diagnostics and treatment that aids clinical decision-making, improving profoundly the way oncology is delivered.
At our core, we "unlock the access" to computerized clinical data, producing real-world evidence (RWE), whose impact weighs heavily on the healthcare industry and the future of oncology care.
We believe that we will be able to provide real-world evidence that is going to have a huge impact on changing the international guidelines for the most frequent cancers and to provide the necessary clinical evidence, to finally establish guidelines for the rarer types of cancer.